Fontana F - Search Results

1

Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy.

Figueiredo P, Lepland A, Scodeller P, Fontana F, Torrieri G, Tiboni M, Shahbazi MA, Casettari L, Kostiainen MA, Hirvonen J, Teesalu T, Santos HA. Figueiredo P, et al. Among authors: fontana f. Acta Biomater. 2021 Oct 1;133:231-243. doi: 10.1016/j.actbio.2020.09.038. Epub 2020 Oct 2. Acta Biomater. 2021. PMID: 33011297

2

Platelet Lysate-Modified Porous Silicon Microparticles for Enhanced Cell Proliferation in Wound Healing Applications.

Fontana F, Mori M, Riva F, Mäkilä E, Liu D, Salonen J, Nicoletti G, Hirvonen J, Caramella C, Santos HA. Fontana F, et al. ACS Appl Mater Interfaces. 2016 Jan 13;8(1):988-96. doi: 10.1021/acsami.5b10950. Epub 2015 Dec 24. ACS Appl Mater Interfaces. 2016. PMID: 26652045

3

Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?

Fontana F, Liu D, Hirvonen J, Santos HA. Fontana F, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jan;9(1). doi: 10.1002/wnan.1421. Epub 2016 Jul 29. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017. PMID: 27470448 Review.

4

Microparticles to enhance delivery of drugs and growth factors into wound sites.

Ranjan S, Fontana F, Ullah H, Hirvonen J, Santos HA. Ranjan S, et al. Among authors: fontana f. Ther Deliv. 2016 Oct;7(10):711-732. doi: 10.4155/tde-2016-0039. Ther Deliv. 2016. PMID: 27790955 Review.

5

Quercetin-Based Modified Porous Silicon Nanoparticles for Enhanced Inhibition of Doxorubicin-Resistant Cancer Cells.

Liu Z, Balasubramanian V, Bhat C, Vahermo M, Mäkilä E, Kemell M, Fontana F, Janoniene A, Petrikaite V, Salonen J, Yli-Kauhaluoma J, Hirvonen J, Zhang H, Santos HA. Liu Z, et al. Among authors: fontana f. Adv Healthc Mater. 2017 Feb;6(3). doi: 10.1002/adhm.201601009. Epub 2016 Dec 12. Adv Healthc Mater. 2017. PMID: 27943644

6

Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy.

Fontana F, Shahbazi MA, Liu D, Zhang H, Mäkilä E, Salonen J, Hirvonen JT, Santos HA. Fontana F, et al. Adv Mater. 2017 Feb;29(7). doi: 10.1002/adma.201603239. Epub 2016 Dec 23. Adv Mater. 2017. PMID: 28009461

7

Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions.

Balasubramanian V, Correia A, Zhang H, Fontana F, Mäkilä E, Salonen J, Hirvonen J, Santos HA. Balasubramanian V, et al. Among authors: fontana f. Adv Mater. 2017 Mar;29(11). doi: 10.1002/adma.201605375. Epub 2017 Jan 23. Adv Mater. 2017. PMID: 28112838

8

Microfluidic-assisted fabrication of carriers for controlled drug delivery.

Liu D, Zhang H, Fontana F, Hirvonen JT, Santos HA. Liu D, et al. Among authors: fontana f. Lab Chip. 2017 May 31;17(11):1856-1883. doi: 10.1039/c7lc00242d. Lab Chip. 2017. PMID: 28480462 Review.

9

Current developments and applications of microfluidic technology toward clinical translation of nanomedicines.

Liu D, Zhang H, Fontana F, Hirvonen JT, Santos HA. Liu D, et al. Among authors: fontana f. Adv Drug Deliv Rev. 2018 Mar 15;128:54-83. doi: 10.1016/j.addr.2017.08.003. Epub 2017 Aug 8. Adv Drug Deliv Rev. 2018. PMID: 28801093 Review.

10

Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy.

Li W, Liu Z, Fontana F, Ding Y, Liu D, Hirvonen JT, Santos HA. Li W, et al. Among authors: fontana f. Adv Mater. 2018 Jun;30(24):e1703740. doi: 10.1002/adma.201703740. Epub 2018 Mar 13. Adv Mater. 2018. PMID: 29534311 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

770 results

Search Page

Filters